{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T20:03:29Z","timestamp":1760472209038},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2010,3,10]],"date-time":"2010-03-10T00:00:00Z","timestamp":1268179200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1007\/bf03346675","type":"journal-article","created":{"date-parts":[[2014,3,27]],"date-time":"2014-03-27T13:20:46Z","timestamp":1395926446000},"page":"712-714","source":"Crossref","is-referenced-by-count":26,"title":["Response to radiation therapy in adrenocortical carcinoma"],"prefix":"10.1007","volume":"33","author":[{"given":"I. G. C.","family":"Hermsen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y. E.","family":"Groenen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. W.","family":"Dercksen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Theuws","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. R.","family":"Haak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,3,10]]},"reference":[{"key":"BF03346675_CR1","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1002\/cncr.10487","volume":"94","author":"J Abraham","year":"2002","unstructured":"Abraham J, Bakke S, Rutt A, et al. A phase II trial of combination chemotherapy and surgical resection for the treatment of metastatic adrenocortical carcinoma: continuous infusion doxorubicin, vincristine, and etoposide with daily mitotane as a P-glycoprotein antagonist. Cancer 2002, 94: 2333\u201343.","journal-title":"Cancer"},{"key":"BF03346675_CR2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s003450050101","volume":"17","author":"RD Schulick","year":"1999","unstructured":"Schulick RD, Brennan MF. Adrenocortical carcinoma. World J Urol 1999, 17: 26\u201334.","journal-title":"World J Urol"},{"key":"BF03346675_CR3","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s10434-999-0719-7","volume":"6","author":"RD Schulick","year":"1999","unstructured":"Schulick RD, Brennan MF. Long-term survival after complete resection and repeat resection in patients with adrenocortical carcinoma. Ann Surg Oncol 1999, 6: 719\u201326.","journal-title":"Ann Surg Oncol"},{"key":"BF03346675_CR4","first-page":"292","volume":"14","author":"NA Samaan","year":"1987","unstructured":"Samaan NA, Hickey RC. Adrenal cortical carcinoma. Semin Oncol 1987, 14: 292\u20136.","journal-title":"Semin Oncol"},{"key":"BF03346675_CR5","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1056\/NEJMoa063360","volume":"356","author":"M Terzolo","year":"2007","unstructured":"Terzolo M, Angeli A, Fassnacht M, et al. Adjuvant mitotane treatment for adrenocortical carcinoma. N Engl J Med 2007, 356: 2372\u201380.","journal-title":"N Engl J Med"},{"key":"BF03346675_CR6","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1056\/NEJM199004263221705","volume":"322","author":"JP Luton","year":"1990","unstructured":"Luton JP, Cerdas S, Billaud L, et al. Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapy. N Engl J Med 1990, 322: 1195\u2013201.","journal-title":"N Engl J Med"},{"key":"BF03346675_CR7","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/0002-9343(66)90220-8","volume":"41","author":"AM Hutter Jr","year":"1966","unstructured":"Hutter AM Jr, Kayhoe DE. Adrenal cortical carcinoma. Results of treatment with o,p\u2019DDD in 138 patients. Am J Med 1966, 41: 581\u201392.","journal-title":"Am J Med"},{"key":"BF03346675_CR8","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1046\/j.1365-2265.2003.01881.x","volume":"60","author":"B Allolio","year":"2004","unstructured":"Allolio B, Hahner S, Weismann D, Fassnacht M. Management of adrenocortical carcinoma. Clin Endocrinol (Oxf) 2004, 60: 273\u201387.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"BF03346675_CR9","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1677\/erc.1.01130","volume":"14","author":"R Libe","year":"2007","unstructured":"Libe R, Fratticci A, Bertherat J. Adrenocortical cancer: pathophysiology and clinical management. Endocr Relat Cancer 2007, 14: 13\u201328.","journal-title":"Endocr Relat Cancer"},{"key":"BF03346675_CR10","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1002\/cncr.24331","volume":"115","author":"B Polat","year":"2009","unstructured":"Polat B, Fassnacht M, Pfreundner L, et al. Radiotherapy in adrenocortical carcinoma. Cancer 2009, 115: 2816\u201323.","journal-title":"Cancer"},{"key":"BF03346675_CR11","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.beem.2008.10.008","volume":"23","author":"M Fassnacht","year":"2009","unstructured":"Fassnacht M, Allolio B. Clinical management of adrenocortical carcinoma. Best Pract Res Clin Endocrinol Metab 2009, 23: 273\u201389.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"BF03346675_CR12","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/j.ejca.2005.04.005","volume":"41","author":"P Therasse","year":"2005","unstructured":"Therasse P, Le CA, Van GM, et al. RECIST vs. WHO: prospective comparison of response criteria in an EORTC phase II clinical trial investigating ET-743 in advanced soft tissue sarcoma. EurJ Cancer 2005, 41: 1426\u201330.","journal-title":"EurJ Cancer"},{"key":"BF03346675_CR13","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1677\/erc.1.01029","volume":"12","author":"DE Schteingart","year":"2005","unstructured":"Schteingart DE, Doherty GM, Gauger PG, et al. Management of patients with adrenal cancer: recommendations of an international consensus conference. Endocr Relat Cancer 2005, 12: 667\u201380.","journal-title":"Endocr Relat Cancer"},{"key":"BF03346675_CR14","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/1097-0142(19890801)64:3<765::AID-CNCR2820640333>3.0.CO;2-I","volume":"64","author":"S Venkatesh","year":"1989","unstructured":"Venkatesh S, Hickey RC, Sellin RV, et al. Adrenal cortical carcinoma. Cancer 1989, 64: 765\u20139.","journal-title":"Cancer"},{"key":"BF03346675_CR15","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/1097-0142(19830815)52:4<707::AID-CNCR2820520424>3.0.CO;2-N","volume":"52","author":"S Nader","year":"1983","unstructured":"Nader S, Hickey RC, Sellin RV, Samaan NA. Adrenal cortical carcinoma. A study of 77 cases. Cancer 1983, 52: 707\u201311.","journal-title":"Cancer"},{"key":"BF03346675_CR16","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/1097-0142(197907)44:1<239::AID-CNCR2820440139>3.0.CO;2-R","volume":"44","author":"DR King","year":"1979","unstructured":"King DR, Lack EE. Adrenal cortical carcinoma: a clinical and pathologic study of 49 cases. Cancer 1979, 44: 239\u201344.","journal-title":"Cancer"},{"key":"BF03346675_CR17","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1002\/1097-0142(19810501)47:9<2153::AID-CNCR2820470908>3.0.CO;2-6","volume":"47","author":"MS Didolkar","year":"1981","unstructured":"Didolkar MS, Bescher RA, Elias EG, Moore RH. Natural history of adrenal cortical carcinoma: a clinicopathologic study of 42 patients. Cancer 1981, 47: 2153\u201361.","journal-title":"Cancer"},{"key":"BF03346675_CR18","first-page":"963","volume":"112","author":"RF Pommier","year":"1992","unstructured":"Pommier RF, Brennan MF. An eleven-year experience with adrenocortical carcinoma. Surgery 1992, 112: 963\u201370.","journal-title":"Surgery"},{"key":"BF03346675_CR19","doi-asserted-by":"crossref","first-page":"4501","DOI":"10.1210\/jc.2006-1007","volume":"91","author":"M Fassnacht","year":"2006","unstructured":"Fassnacht M, Hahner S, Polat B, et al. Efficacy of adjuvant radiotherapy of the tumor bed on local recurrence of adrenocortical carcinoma. J Clin Endocrinol Metab 2006, 91: 4501\u20134.","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03346675.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03346675\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03346675","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T10:43:09Z","timestamp":1558521789000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03346675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,10]]},"references-count":19,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["BF03346675"],"URL":"https:\/\/doi.org\/10.1007\/bf03346675","relation":{},"ISSN":["0391-4097","1720-8386"],"issn-type":[{"value":"0391-4097","type":"print"},{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3,10]]}}}